Tus kws kho mob
P44-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates: Effective October 3, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1301 - 1310 ntawm 4303
Tus kws kho mob
P45-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P46-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P47-22 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P48-22 Reimbursement Policy Update for -CO and -CQ Modifiers for Minnesota Health Care Programs
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P49-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tus kws kho mob
2022 August Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2022
Tus kws kho mob
QP61-22 Free Continuing Education for Mental Health Providers through 12/31/22
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2022
Tus kws kho mob
QP62-22 Commercial Pharmacy Benefit Exclusion for Propel®, Propel Mini®, Sinuva®
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2022
Tus kws kho mob
QP63-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Ryplazim® (plasminogen, human-tvmh)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2022